Heart Price To Sales Ratio from 2010 to 2024
| HSCS Stock | USD 2.67 0.05 1.91% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 175.12283871 | Current Value 348.82 | Quarterly Volatility 316.19069326 |
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
Heart | Price To Sales Ratio |
Latest Heart Test's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Heart Test Laboratories over the last few years. Price to Sales Ratio is figured by comparing Heart Test Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Heart Test sales, a figure that is much harder to manipulate than other Heart Test Laboratories multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Heart Test's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 131.17 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Heart Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 221.26 | |
| Geometric Mean | 141.72 | |
| Coefficient Of Variation | 142.90 | |
| Mean Deviation | 184.30 | |
| Median | 87.77 | |
| Standard Deviation | 316.19 | |
| Sample Variance | 99,977 | |
| Range | 1.2K | |
| R-Value | 0.51 | |
| Mean Square Error | 79,910 | |
| R-Squared | 0.26 | |
| Significance | 0.05 | |
| Slope | 35.90 | |
| Total Sum of Squares | 1.4M |
Heart Price To Sales Ratio History
About Heart Test Financial Statements
Heart Test shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 175.12 | 348.82 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.